Quality by Design Approach for Development and Validation of Analytical Method for Estimation of Furosemide in Bulk and Formulation
Journal of Applied Pharmaceutical Sciences and Research · 12.06.2026 · 9 (02) · 71-83
DOI: 10.31069/japsr.v9i2.07 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Pharmaceutical Sciences and Research, online erschienen am 12.06.2026. Verfasst von Ankita Gulhane und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Background
A common loop diuretic used to manage edema, CHF, and hypertension is furosemide. The majority of described HPLCtechniques for its estimation are linked to longer run times and higher solvent consumption, and they lack a systematic Quality byDesign (QbD) approach.
Objectives
Using a QbD methodology, the current work sought to design and validate a reliable, quick, and economical HPLC techniquefor furosemide quantification in pharmaceutical formulations and bulk. Materials and Methods: A central composite design was used to improve crucial procedure parameters like flow rate and mobile phasecomposition. Chromatographic separation was carried out using a column C18 with acetonitrile and 0.1% OPA (70:30 v/v) as the mobilephase at a flow rate 0.8 mL/min and detection at 277 nm. In compliance with ICH Q2(R1) standards, the developed method was verifiedfor linearity, accuracy, precision, robustness, ruggedness, LOD, and LOQ.
Results
With a correlation coefficient (R2) of 0.9994, the method show outstanding linearity over the range of 5–30 ppm. Precision studiesindicated %RSD values below 2%, while accuracy studies showed recovery between 98–102%. It was discovered that the approachwas strong and resilient, with little change under various circumstances instruments. The results showed that the LOD and LOQ were0.65 μg/mL and 1.97 μg/mL, respectively. Summary: The new QbD-based RP-HPLC method is simple, precise, and appropriate for routine quantitative analysis of furosemide inbulk and medicinal dose forms.
Zitieren
APA
Gulhane, A., Ruikar, D., Welankiwar, A., Sarode, S., & Vyas, S. (2026). Quality by Design Approach for Development and Validation of Analytical Method for Estimation of Furosemide in Bulk and Formulation. Journal of Applied Pharmaceutical Sciences and Research, 9(02), 71-83. https://doi.org/10.31069/japsr.v9i2.07
Vancouver
Gulhane A, Ruikar D, Welankiwar A, Sarode S, Vyas S. Quality by Design Approach for Development and Validation of Analytical Method for Estimation of Furosemide in Bulk and Formulation. Journal of Applied Pharmaceutical Sciences and Research. 2026;9(02):71-83. doi:10.31069/japsr.v9i2.07
BibTeX
@article{Gulhane2026,
author = {Gulhane, Ankita and Ruikar, Dipti and Welankiwar, Abhijeet and Sarode, Shreya and Vyas, Siddhi},
title = {Quality by Design Approach for Development and Validation of Analytical Method for Estimation of Furosemide in Bulk and Formulation},
journal = {Journal of Applied Pharmaceutical Sciences and Research},
year = {2026},
volume = {9},
number = {02},
pages = {71--83},
doi = {10.31069/japsr.v9i2.07}
}
EUVIMED